To test the hypothesis that MIAT participates in liver fibrosis progression, HSCs were treated with adenoviral vectors expressing short hairpin RNA against MIAT (Ad-shMIAT) to silence MIAT level. Here, MIAT is linked to Hepatic fibrosis.